Expression of N-myc and c-src during the development of fetal human brain
- PMID: 3552210
Expression of N-myc and c-src during the development of fetal human brain
Abstract
We studied N-myc RNA by in situ hybridization and S1 nuclease protection analysis in human fetal cerebrum, retina, lung, liver, and placenta during the second trimester. High levels of N-myc RNA were found in the early fetal cerebral germinal layer and the primordial cortex, with lower levels in the intermediate layer. After the twentieth week, N-myc expression declined in the attenuated germinal layer, remained high in the undifferentiated outer cortex, but declined in the differentiating inner cortex, which now expressed c-src. The primitive retina had high levels of N-myc RNA in the inner nuclear and ganglion cell layers between 12 and 21 weeks of fetal age. During this time, c-src RNA increased with fetal age in the ganglion cell layer. Lower levels of N-myc RNA were expressed in some cells of lung and placenta. Thus, appreciable N-myc RNA elevation is present in immature neural cells, disappears with differentiation, and may be unrelated to mitosis since high levels occur in the primordial cortex, which grows by accretion, and not by cell division.
Similar articles
-
Expression of the myc proto-oncogenes in developing human fetal brain.Oncogene. 1990 Dec;5(12):1787-97. Oncogene. 1990. PMID: 2284098
-
Localization of cellular src mRNA during development and in the differentiated bipolar neurons of the adult neural retina in Xiphophorus.Oncogene Res. 1989;5(1):39-47. Oncogene Res. 1989. PMID: 2780053
-
N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation.J Cell Physiol. 1986 May;127(2):274-80. doi: 10.1002/jcp.1041270213. J Cell Physiol. 1986. PMID: 3700483
-
Defective development of the embryonic liver in N-myc-deficient mice.Dev Biol. 1998 Mar 1;195(1):16-28. doi: 10.1006/dbio.1997.8823. Dev Biol. 1998. PMID: 9520320
-
The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.Anticancer Res. 1993 Sep-Oct;13(5A):1373-85. Anticancer Res. 1993. PMID: 8239508 Review.
Cited by
-
Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.Thorac Cancer. 2021 Oct;12(20):2789-2795. doi: 10.1111/1759-7714.14126. Epub 2021 Aug 31. Thorac Cancer. 2021. PMID: 34464028 Free PMC article.
-
The MYCN Protein in Health and Disease.Genes (Basel). 2017 Mar 30;8(4):113. doi: 10.3390/genes8040113. Genes (Basel). 2017. PMID: 28358317 Free PMC article. Review.
-
N-myc oncogene amplification in a pediatric case of glioblastoma multiforme.Childs Nerv Syst. 1991 Nov;7(7):410-3. doi: 10.1007/BF00304209. Childs Nerv Syst. 1991. PMID: 1665398
-
MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coin.Front Oncol. 2013 Mar 11;3:42. doi: 10.3389/fonc.2013.00042. eCollection 2013. Front Oncol. 2013. PMID: 23482921 Free PMC article.
-
Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.EMBO J. 1995 Nov 15;14(22):5646-59. doi: 10.1002/j.1460-2075.1995.tb00252.x. EMBO J. 1995. PMID: 8521822 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous